Clinical Trial ALYATEC CATS

 

 

 

 

 

 

 

 

ALYATEC participated in the “CATS” clinical study in 2022 and 2023 which aimed to determine if cat food helps reducing allergic symptoms in cat owners.

The results were published in the scientific journal Clinical and Translational Allergy. The study showed that a cat diet containing anti‐Fel d 1 antibodies can significantly reduce participants’ allergic symptoms and reduce their impact on work productivity.

 

All information related to the study can be found in the article:

Bousquet J, Gherasim A, de Blay F, et al. Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air® app. Clin Transl Allergy. 2024; e12353. https://doi.org/10.1002/clt2.12353

 

 

Centre d'essais cliniques Alyatec